Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy

INTRODUCTION: The Livial Intervention Following Breast Cancer: Efficacy, Recurrence and Tolerability Endpoints (LIBERATE: Clinical http://Trials.gov number NCT00408863), a randomized, placebo-controlled, double-blind trial that demonstrated that tibolone (Livial), a tissue-selective hormone-replacem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bundred, Nigel J, Kenemans, Peter, Yip, Cheng Har, Beckmann, Matthias W, Foidart, Jean-Michel, Sismondi, Piero, Schoultz, Bo von, Vassilopoulou-Sellin, Rena, Galta, Rachid El, Lieshout, Eugenie Van, Mol-Arts, Mirjam, Planellas, Juan, Kubista, Ernst
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496130/
https://ncbi.nlm.nih.gov/pubmed/22251615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3097
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados